KR102151758B1 - Aromatic aroma composition for enhancing concentration of human brain and uses thereof - Google Patents
Aromatic aroma composition for enhancing concentration of human brain and uses thereof Download PDFInfo
- Publication number
- KR102151758B1 KR102151758B1 KR1020190019916A KR20190019916A KR102151758B1 KR 102151758 B1 KR102151758 B1 KR 102151758B1 KR 1020190019916 A KR1020190019916 A KR 1020190019916A KR 20190019916 A KR20190019916 A KR 20190019916A KR 102151758 B1 KR102151758 B1 KR 102151758B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- oil
- fragrance
- increasing concentration
- perfume
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 210000004556 brain Anatomy 0.000 title description 22
- 125000003118 aryl group Chemical group 0.000 title description 12
- 230000002708 enhancing effect Effects 0.000 title 1
- 239000003205 fragrance Substances 0.000 claims abstract description 64
- 238000001228 spectrum Methods 0.000 claims abstract description 45
- 239000002304 perfume Substances 0.000 claims abstract description 40
- 230000001965 increasing effect Effects 0.000 claims abstract description 34
- 210000001652 frontal lobe Anatomy 0.000 claims abstract description 30
- 230000000694 effects Effects 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 12
- 230000003595 spectral effect Effects 0.000 claims abstract description 11
- 235000013376 functional food Nutrition 0.000 claims abstract description 7
- 230000036541 health Effects 0.000 claims abstract description 7
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims description 30
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 claims description 28
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 26
- 239000001631 piper nigrum l. fruit oil black Substances 0.000 claims description 18
- 235000019501 Lemon oil Nutrition 0.000 claims description 17
- 239000010501 lemon oil Substances 0.000 claims description 17
- 239000010627 cedar oil Substances 0.000 claims description 16
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims description 16
- FINOAUDUYKVGDS-UHFFFAOYSA-N (2-tert-butylcyclohexyl) acetate Chemical compound CC(=O)OC1CCCCC1C(C)(C)C FINOAUDUYKVGDS-UHFFFAOYSA-N 0.000 claims description 15
- DNRJTBAOUJJKDY-UHFFFAOYSA-N 2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene Chemical compound CC(=O)C1=C(C)C=C2C(C)(C)C(C)CC(C)(C)C2=C1 DNRJTBAOUJJKDY-UHFFFAOYSA-N 0.000 claims description 15
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 claims description 15
- 239000010668 rosemary oil Substances 0.000 claims description 15
- 229940058206 rosemary oil Drugs 0.000 claims description 15
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 claims description 14
- KHQDWCKZXLWDNM-KPKJPENVSA-N (e)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol Chemical compound CC\C(CO)=C/CC1CC=C(C)C1(C)C KHQDWCKZXLWDNM-KPKJPENVSA-N 0.000 claims description 14
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 claims description 14
- 229930008394 dihydromyrcenol Natural products 0.000 claims description 14
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 14
- ONKNPOPIGWHAQC-UHFFFAOYSA-N galaxolide Chemical compound C1OCC(C)C2=C1C=C1C(C)(C)C(C)C(C)(C)C1=C2 ONKNPOPIGWHAQC-UHFFFAOYSA-N 0.000 claims description 14
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 claims description 14
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 claims description 14
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 13
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 13
- RDHNTAXPFZIMDN-UHFFFAOYSA-N 6,6-Dimethoxy-2,5,5-trimethyl-2-hexene Chemical compound COC(OC)C(C)(C)CC=C(C)C RDHNTAXPFZIMDN-UHFFFAOYSA-N 0.000 claims description 13
- 241000234269 Liliales Species 0.000 claims description 13
- YPZUZOLGGMJZJO-UHFFFAOYSA-N ambrofix Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OCC2 YPZUZOLGGMJZJO-UHFFFAOYSA-N 0.000 claims description 13
- 229930007744 linalool Natural products 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 12
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 claims description 12
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 claims description 11
- SWUIQEBPZIHZQS-UHFFFAOYSA-N calone Chemical compound O1CC(=O)COC2=CC(C)=CC=C21 SWUIQEBPZIHZQS-UHFFFAOYSA-N 0.000 claims description 11
- HRGPYCVTDOECMG-RHBQXOTJSA-N methyl cedryl ether Chemical compound C1[C@@]23[C@H](C)CC[C@H]2C(C)(C)[C@]1([H])[C@@](OC)(C)CC3 HRGPYCVTDOECMG-RHBQXOTJSA-N 0.000 claims description 11
- GTNCESCYZPMXCJ-UHFFFAOYSA-N 3-Phenylpropyl propanoate Chemical compound CCC(=O)OCCCC1=CC=CC=C1 GTNCESCYZPMXCJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 abstract 1
- 235000013599 spices Nutrition 0.000 description 13
- 230000001256 tonic effect Effects 0.000 description 10
- FVUGZKDGWGKCFE-BDJLRTHQSA-N iso e super Chemical compound CC1(C)CCCC2=C1C[C@](C(C)=O)(C)[C@H](C)C2 FVUGZKDGWGKCFE-BDJLRTHQSA-N 0.000 description 7
- -1 linalul Chemical compound 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 230000037007 arousal Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000007177 brain activity Effects 0.000 description 4
- 210000003710 cerebral cortex Anatomy 0.000 description 4
- 210000001152 parietal lobe Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 230000003920 cognitive function Effects 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 description 2
- 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 235000013614 black pepper Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000008821 Menyanthes trifoliata Species 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- KVWWIYGFBYDJQC-GHMZBOCLSA-N Methyl dihydrojasmonate Chemical compound CCCCC[C@@H]1[C@@H](CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-GHMZBOCLSA-N 0.000 description 1
- 241001416180 Moschidae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000012547 Olfactory receptors Human genes 0.000 description 1
- 108050002069 Olfactory receptors Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000283249 Physeteridae Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000020831 absolute fast Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000011840 criminal investigation Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000869 occipital lobe Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000002475 olfactory pathway Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002360 prefrontal effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000003304 psychophysiological effect Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000003478 temporal lobe Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0069—Heterocyclic compounds
- C11B9/0073—Heterocyclic compounds containing only O or S as heteroatoms
- C11B9/008—Heterocyclic compounds containing only O or S as heteroatoms the hetero rings containing six atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0003—Compounds of unspecified constitution defined by the chemical reaction for their preparation
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0007—Aliphatic compounds
- C11B9/0015—Aliphatic compounds containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
- C11B9/0034—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0042—Essential oils; Perfumes compounds containing condensed hydrocarbon rings
- C11B9/0046—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings
- C11B9/0049—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms
- C11B9/0053—Essential oils; Perfumes compounds containing condensed hydrocarbon rings containing only two condensed rings the condensed rings sharing two common C atoms both rings being six-membered
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Cosmetics (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 집중력 증가용 향료 조성물, 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품 및 화장료 조성물과 집중력 증가 효과를 지니는 향료 혼합물의 제조방법 및 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물에 관한 것으로, 본 발명의 향료 조성물은 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하여 집중력 강화 효과가 있다.The present invention relates to a perfume composition for increasing concentration, a health functional food and cosmetic composition for increasing concentration including the perfume composition and a method for preparing a perfume mixture having an effect of increasing concentration, and a perfume mixture having an effect of increasing concentration prepared by the method As such, the fragrance composition of the present invention has an increase in RG (relative gamma power spectrum) in the central and right frontal lobes, an increase in RLB (relative low beta power spectrum) in the central and right frontal lobes, and SEF50 (Spectral edge) in the right frontal lobe frequency 50%) increases and has an effect of strengthening concentration.
Description
본 발명은 집중력 증가용 향료 조성물, 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품 및 화장료 조성물과 집중력 증가 효과를 지니는 향료 혼합물의 제조방법 및 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물에 관한 것이다.The present invention relates to a perfume composition for increasing concentration, a health functional food and cosmetic composition for increasing concentration including the perfume composition and a method for preparing a perfume mixture having an effect of increasing concentration, and a perfume mixture having an effect of increasing concentration prepared by the method will be.
향수는 휘발성의 향기 화합물 원료인 정유(essential oils)를 에탄올로 희석한 제품으로 이를 만드는데 들어가는 향료는 천연향료와 합성향료로 나뉜다. 천연향료는 동물로부터 얻는 동물향료와 식물로부터 얻는 식물향료로 나뉜다. 동물향료로는 향류고래로부터 얻는 앰버그리스(ambergris), 사향노루로부터 얻는 무스크(musk), 사향고양이로부터 얻는 시벳(vivette), 비버로부터 얻는 캐스토리움(castorium)이 있지만 요즈음은 잘 사용되고 있지 않다. 식물향료는 약 1,500여 종의 식물의 꽃, 잎, 과실, 종자, 수지, 뿌리, 줄기를 증류, 추출, 압착 등의 방법으로 얻을 수 있지만 순도가 낮고, 추출 및 증류시 향취 변화가 심하며, 생산지역, 수확시기 및 수확후 보관방법에 따라 강도와 품질변화가 심하며, 공급 불확실성이 크기 때문에 지금은 약 200여 종 정도가 시장에서 시판되고 있다.Perfume is a product obtained by diluting essential oils, a raw material of volatile fragrance compounds, with ethanol. The fragrances used to make them are divided into natural fragrances and synthetic fragrances. Natural fragrances are divided into animal fragrances obtained from animals and plant fragrances obtained from plants. Animal flavors include ambergris from sperm whales, musk from musk deer, vivette from musk cats, and castorium from beavers, but these days are not used well. Plant fragrances can be obtained by distilling, extracting, and compressing flowers, leaves, fruits, seeds, resins, roots, and stems of about 1,500 kinds of plants, but the purity is low, and the scent change is severe during extraction and distillation. Depending on the region, harvest time and post-harvest storage method, the intensity and quality vary greatly, and supply uncertainty is large, so about 200 species are currently on the market.
유기합성 향료는 실험실에서 유기합성을 통해 얻을 수 있는데 천연향보다는 순도가 높아 사용하기 저렴하고, 안정적이며 보존기간이 길고, 농도가 높으며, 계절적 공급에 문제가 없기 때문에 향료업계에서는 주로 많이 선호되고 있다. 유기합성 향료의 대표적인 예로는 샤넬 No.5에 사용되는 알데히드를 들 수 있다.Organic-synthetic fragrances can be obtained through organic synthesis in a laboratory. They are more pure than natural fragrances, so they are cheap to use, are stable, have a long shelf life, have a high concentration, and have no problems with seasonal supply, so they are mostly preferred in the fragrance industry. . Representative examples of organic synthetic fragrances include aldehydes used in Chanel No.5.
향료 하나하나는 각각의 독특하고 고유한 향취를 나타내는데 이를 향조 또는 노트라고 한다. 향조는 일반적으로 시트러스(citrus), 플로랄(floral), 그린(green), 프루티(fruity), 알데히드(aldehyde), 오리엔탈(oriental), 스파이시(spicy), 우디(woody), 시프레(psypre), 후제아(fougere), 마린(marine), 그리고 구루망(gourmand)으로 나타낸다. 향료를 여러 개를 섞으면 각각의 향료가 나타내는 향취가 변하게 된다. 단품 향료를 여러 개를 섞는 것을 조향이라고 하는데 이를 통해서 다양한 향취를 갖는 조합향료 제품을 만들 수 있다. 조합향료는 용도에 따라서 프래그런스(방향향료)와 플래버(식품향료)로 나뉜다. 프래그런스는 정유의 함유량에 따라 제품의 명칭은 향수(15-30%), 오 드 퍼퓸(15-18%), 오 드 토일렛(4-8%), 오 드 코롱(3-5%) 등으로 구분된다. 일반적으로 조합향료를 섞어 새로운 향료제품을 만들고자 할 때에는 뿌렸을 때 향이 즉시 나타나는 탑 노트, 향의 특징을 잘 나타내는 미들 노트, 그리고 향기에 깊이와 볼륨을 부여하는 라스트 노트가 상호 조화를 이루어야 한다.Each fragrance represents a unique and unique fragrance, which is called a fragrance or note. Flavor is generally citrus, floral, green, fruity, aldehyde, oriental, spicy, woody, psypre, and Denoted as fougere, marine, and gourmand. Mixing several flavors changes the scent of each flavor. Mixing several single flavors is called scent, and through this, you can make a combination fragrance product with a variety of flavors. Combination fragrances are divided into fragrance (fragrance) and flavor (food fragrance) depending on the purpose. According to the content of essential oils, fragrances are named perfume (15-30%), eau de parfum (15-18%), eau de toilette (4-8%), and eau de cologne (3-5%). It is distinguished. In general, when you want to make a new fragrance product by mixing combination fragrances, the top note that the fragrance immediately appears when sprayed, the middle note that shows the characteristics of the fragrance well, and the last note that gives depth and volume to the fragrance must be in harmony with each other.
인간이 향수를 흡입하게 되면 향기분자들이 비강을 따라 이동하여 후각수용체(olfactory receptors)와 결합하면 전기적인 신호가 발생한다. 이때 발생하는 전기적인 신호가 후구(olfactory bulb)에 있는 후각로(olfactory tract)를 따라 대뇌피질에 전달되면 뇌 활성화가 이루어진다. 향료에 함유된 냄새분자는 인간의 뇌에 영향을 주어 뇌파를 변화시키고 생리적, 심리적 변화를 유도하는 것으로 알려져 있다.When humans inhale perfume, scent molecules move along the nasal cavity and bind to olfactory receptors, generating electrical signals. When the electrical signal generated at this time is transmitted to the cerebral cortex along the olfactory tract in the olfactory bulb, the brain is activated. Smell molecules contained in perfume are known to affect the human brain to change brain waves and induce physiological and psychological changes.
대뇌피질이 어떤 자극에 의해 활성화가 이루어지면 뇌파(brain wave)가 발생하는데 뇌파는 인간의 대뇌피질의 신경계에서 뉴런들 사이에서 발생한 전기 신호이다. 두피에 대뇌 전기 활성을 증폭시킬 수 있는 전극을 붙이고 얻은 파형을 그래프로 기록하고 이를 분석하며 뇌의 자율적인 활동에 의하여 발생되는 전기적인 신호인 뇌파는 뇌의 활동을 기록하고 관찰함으로써 인간에 뇌에 관한 각성, 활성, 불안 및 안정 등의 인간의 정신 생리적 기능을 나타내주는 지표로 활용된다. 뇌파는 객관적, 비침습적, 연속적으로 기록하고 측정할 수 있는 장점을 가지고 있기 때문에 인지과학, 의학, 약학, 범죄조사 등에 활용되고 있다.When the cerebral cortex is activated by a certain stimulus, brain waves are generated, which are electrical signals generated between neurons in the nervous system of the human cerebral cortex. Electrodes that can amplify cerebral electrical activity are attached to the scalp, and the obtained waveform is recorded as a graph and analyzed. EEG, an electrical signal generated by the brain's autonomous activity, records and observes the activity of the brain. It is used as an indicator of human psychophysiological functions such as arousal, activity, anxiety and stability. Since EEG has the advantage of being able to record and measure objectively, non-invasively, and continuously, it is used in cognitive science, medicine, pharmacy, and criminal investigations.
뇌파는 주로 0~60 Hz 주파수와 5~300 uV의 진폭을 나타내는데 주파수의 범위에 따라 delta파(0~4 Hz), theta파(4~8 Hz), alpha파(8~13 Hz), beta파(13~30 Hz), gamma파(30~50 Hz)로 나뉜다. Delta파, theta파는 서파(slow wave)이며 두뇌 내부의 정보를 활용해 생각하고 활동할 시에 나타난다. Alpha파보다 높은 beta파는 속파(fast wave)이다. 뇌파분석에서는 절대 파워값(absolute power)뿐만 아니라 두개골의 두께 차이, 두피의 전기적 상태, 긴장도와 같은 개인차를 줄이고 정확한 뇌파반응을 분석할 수 있는 상대 파워값(relative power)이 사용된다.EEG mainly shows a frequency of 0 to 60 Hz and an amplitude of 5 to 300 uV, depending on the frequency range, delta wave (0 to 4 Hz), theta wave (4 to 8 Hz), alpha wave (8 to 13 Hz), beta It is divided into wave (13~30 Hz) and gamma wave (30~50 Hz). Delta waves and theta waves are slow waves and appear when you think and act using information inside your brain. Beta waves higher than Alpha waves are fast waves. In EEG analysis, not only absolute power, but also relative power, which can reduce individual differences such as skull thickness difference, scalp electrical state, and tension, and analyze accurate EEG responses, are used.
한국등록특허 제1349592호에는 심신을 이완시키고 안정을 유도하는 조합향료 조성물이 개시되어 있고, 한국공개특허 제2012-0131970호에는 스트레스 완화 및 진정효과를 갖는 향료 조성물이 개시되어 있으나, 본 발명의 두뇌의 집중력을 향상시키는 아로마틱 향료 조성물과는 상이하다.Korean Patent Registration No.1349592 discloses a combination perfume composition that relaxes the mind and body and induces stability, and Korean Patent Publication No. 2012-0131970 discloses a perfume composition having stress relief and soothing effects, but the brain of the present invention It is different from the aromatic fragrance composition that improves the concentration of the body.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일의 24가지 물질을 포함하는 향료 조성물이 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above requirements, and the inventors of the present invention provide dihydro myrcenol, linalul, linalyl acetate, methyl pamplemos, verdox, ethyl linalul, beta ionone, cedrember, lilyal, Isoi Super, Calon, Ambrofix, Cis-3-Hexenyl Silicylate, Hedione, Galaxolide, Tonalide, Helional, Bakdanol, Lemon Oil, Cedarwood Oil, Rosemary Oil, Bergamot Oil, D A fragrance composition containing 24 substances of propylene glycol and black pepper oil showed an increase in the relative gamma power spectrum (RG) in the central and right frontal lobe, and the relative low beta power spectrum (RLB) in the central and right frontal lobe. , By confirming inducing an increase in SEF50 (Spectral edge frequency 50%) in the right frontal lobe, the present invention was completed.
상기 과제를 해결하기 위해, 본 발명은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일이 혼합된 향료 혼합물을 유효성분으로 함유하는 집중력 증가용 향료 조성물을 제공한다.In order to solve the above problems, the present invention provides dihydro myrsenol, linalul, linalyl acetate, methyl pamplemos, verdox, ethyl linalul, beta ionone, cedrember, lilial, isoi super, calon, Ambrofix, cis-3-hexenyl silicylate, hedione, galaxolide, tonalide, helional, bakdanol, lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a perfume composition for increasing concentration containing the mixed perfume mixture as an active ingredient.
또한, 본 발명은 상기 향료 조성물을 포함하는 집중력 증가용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for increasing concentration comprising the fragrance composition.
또한, 본 발명은 상기 향료 조성물을 포함하는 집중력 증가용 화장료 조성물을 제공한다.In addition, the present invention provides a cosmetic composition for increasing concentration comprising the perfume composition.
또한, 본 발명은 디하이드로 미르세놀, 리나룰, 리날릴 아세테이트, 메틸 팜플레모스, 버독스, 에틸 리나룰, 베타 이오논, 세드렘버, 릴리알, 아이소 이 수퍼, 칼론, 암브로픽스, 시스-3-헥세닐 실리실레이트, 헤디온, 갈락솔라이드, 토날라이드, 헬리오날, 박다놀, 레몬 오일, 시더우드 오일, 로즈마리 오일, 버가못 오일, 디프로필렌 글리콜 및 블랙페퍼 오일을 혼합하여 제조하는 것을 특징으로 하는 집중력 증가 효과를 지니는 향료 혼합물의 제조방법을 제공한다.In addition, the present invention is dihydro myrsenol, linalul, linalyl acetate, methyl pamphlemos, verdox, ethyl linalul, beta ionone, cedrember, lilial, isoi super, calon, ambrofix, cis -3-Hexenyl silicylate, hedione, galaxolide, tonalide, helional, bakdanol, lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a method for producing a flavor mixture having a concentration increasing effect, characterized in that.
또한, 본 발명은 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물을 제공한다.In addition, the present invention provides a fragrance mixture having an effect of increasing concentration prepared by the above method.
본 발명의 향료 조성물은 향료 흡입을 통해, 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)가 증가하고, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)가 증가하고, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)가 증가하여 집중력을 높이는 효과를 얻을 수 있다. 또한, 본 발명의 향료 조성물은 향장 향료(fragrance)와 식품 향료(flavor) 등의 원료로 사용할 수 있어 다양한 향장산업용 제품에 이용될 수 있을 뿐만 아니라, 식품에 첨가하여 집중력을 높이는 기능의 뉴로푸드(NeuroFood)의 개발에도 활용될 수 있다.The perfume composition of the present invention increases the relative gamma power spectrum (RG) in the central frontal lobe and the right frontal lobe, increases the RLB (Relative low beta power spectrum) in the central frontal lobe and the right frontal lobe, and SEF50 in the right frontal lobe. (Spectral edge frequency 50%) can be increased to increase concentration. In addition, the fragrance composition of the present invention can be used as a raw material such as fragrance and food flavor, so it can be used not only in a variety of products for the fragrance industry, but also added to food to increase concentration. NeuroFood) can also be used.
도 1은 뇌파측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10-20 국제표준 전극부착법을 보여주는 사진이다.
도 2는 피험자의 두뇌에 뇌전도(electroencephalogram, EEG)용 모자를 씌우고 뇌파를 측정하는 모습을 보여주는 사진이다.1 is a photograph showing a 10-20 international standard electrode attachment method showing a region where electrodes are attached to a human brain for EEG measurements.
FIG. 2 is a photograph showing an electroencephalogram (EEG) cap on a subject's brain and measuring an EEG.
본 발명의 목적을 달성하기 위하여, 본 발명은 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리날릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol) 및 블랙페퍼 오일(black pepper oil)이 혼합된 향료 혼합물을 유효성분으로 함유하는 집중력 증가용 향료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention is dihydro myrcenol (dihydro myrcenol), linalool (linalool), linalyl acetate (linalyl acetate), methyl pamplemousse (methyl pamplemousse), verdox (verdox), Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis -3-hexenyl salicylate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide (helional), bacdanol (bacdanol), A flavoring mixture of lemon oil, cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a fragrance composition for increasing concentration containing as an active ingredient.
본 발명의 향료 조성물에서, 상기 향료 혼합물은 바람직하게는 디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%로 이루어진 것일 수 있으며,In the perfume composition of the present invention, the perfume mixture is preferably dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt%, linalyl acetate 0.8 to 1.2 wt% %, methyl pamplemousse 2.3~2.7 wt%, verdox 2.8~3.2 wt%, ethyl linalool 1.3~1.7 wt%, beta ionone 2.8~3.2 Wt%, Cedramber 1.7~2.1 wt%, lilial 7.7~8.3 wt%, isoe super 9.2~9.8 wt%, Calone 0.35~0.45 wt%, cancer Brofix 1.8 to 2.2 wt%, cis-3-hexenyl salicylate 3.3 to 3.7 wt%,
더욱 바람직하게는 디하이드로 미르세놀(dihydro myrcenol) 2.5 중량%, 리나룰(linalool) 1 중량%, 리날릴 아세테이트(linalyl acetate) 1 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.5 중량%, 버독스(verdox) 3 중량%, 에틸 리나룰(ethyl linalool) 1.5 중량%, 베타 이오논(beta ionone) 3 중량%, 세드렘버(cedramber) 1.9 중량%, 릴리알(lilial) 8 중량%, 아이소 이 수퍼(iso e super) 9.5 중량%, 칼론(calone) 0.4 중량%, 암브로픽스(ambrofix) 2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.5 중량%, 헤디온(hedione) 10.5 중량%, 갈락솔라이드(galaxolide 50 ipm) 10 중량%, 토날라이드(tonalide) 4 중량%, 헬리오날(helional) 0.5 중량%, 박다놀(bacdanol) 1 중량%, 레몬 오일(lemon oil) 5 중량%, 시더우드 오일(cedarwood oil) 1 중량%, 로즈마리 오일(rosemary oil) 1 중량%, 버가못 오일(bergamot oil) 1 중량%, 디프로필렌 글리콜(dipropylene glycol) 25.7 중량% 및 블랙페퍼 오일(black pepper oil) 0.5 중량%로 이루어진 것일 수 있다.More preferably dihydro myrcenol (dihydro myrcenol) 2.5% by weight, linalool (linalool) 1% by weight, linalyl acetate (linalyl acetate) 1% by weight, methyl pamplemousse (methyl pamplemousse) 2.5% by weight, Burdox (verdox) 3 wt%, ethyl linalool 1.5 wt%,
본 발명의 향료 조성물은 중앙 전전두엽 및 우측 전두엽에서 RG(Relative gamma power spectrum)의 증가를, 중앙 두정엽 및 우측 전두엽에서 RLB(Relative low beta power spectrum)의 증가를, 우측 전두엽에서 SEF50(Spectral edge frequency 50%)의 증가를 유도하여 집중력 증가 효과를 나타내는 것을 특징으로 한다.The fragrance composition of the present invention has an increase in RG (relative gamma power spectrum) in the central and right frontal lobes, an increase in RLB (relative low beta power spectrum) in the central and right frontal lobes, and SEF50 (Spectral edge frequency 50) in the right frontal lobe. %) to increase concentration.
RG는 전체 중 Gamma파의 비율을 의미하며, Gamma파는 추리, 판단 등의 고도의 인지작용 시 활성화된다고 알려져 있다. RLB는 전체에서 low beta파의 비율을 의미하는 것이고, beta파는 일반적인 작업을 하거나 의식적인 행동을 할 때 나타나며 정신활동이 있을 때 활성화된다. SEF50은 특정 주파수 값까지의 면적이 주파수 영역에 대한 면적의 50%를 차지하는 해당 특정 주파수 값을 의미한다.RG means the ratio of Gamma waves among the total, and Gamma waves are known to be activated during highly cognitive actions such as reasoning and judgment. RLB refers to the ratio of low beta waves in the whole, and beta waves appear when you perform general tasks or conscious actions, and are activated when there is mental activity. SEF50 means a specific frequency value in which the area up to a specific frequency value occupies 50% of the area for the frequency domain.
본 발명은 또한, 본 발명은 향료 조성물을 포함하는 집중력 증가용 건강기능식품을 제공한다.The present invention also provides a health functional food for increasing concentration comprising a perfume composition.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional food includes various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavoring agents, coloring agents and enhancers (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, It may contain pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonates used in carbonated beverages, and the like. In addition, it may contain pulp for the manufacture of natural fruit juices and vegetable beverages. These components may be used independently or in combination.
본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다.The health functional food of the present invention may contain various flavoring agents or natural carbohydrates as additional ingredients. The natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as taumatin and stevia extract, and synthetic sweeteners such as saccharin and aspartame can be used.
본 발명은 또한, 본 발명의 향료 조성물을 포함하는 집중력 증가용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for increasing concentration comprising the perfume composition of the present invention.
상기 화장료 조성물은 유연화장수, 수렴화장수, 영양화장수, 영양로션, 영양에센스, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징크림, 클렌징폼, 클렌징워터, 팩, 젤, 파우더, 메이크업베이스, 바디로션, 바디크림, 바디오일, 바디에센스, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택되는 제형을 갖는 것이 바람직하지만 이에 한정하지 않는다.The cosmetic composition is a softening lotion, astringent lotion, nourishing lotion, nourishing lotion, nourishing essence, nourishing cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, pack, gel, powder, makeup base , Body lotion, body cream, body oil, body essence, lotion, ointment, gel, cream, patch, and spray, it is preferable to have a formulation selected from the group consisting of, but is not limited thereto.
본 발명은 또한, 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리날릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol) 및 블랙페퍼 오일(black pepper oil)을 혼합하여 제조하는 것을 특징으로 하는 집중력 증가 효과를 지니는 향료 혼합물의 제조방법을 제공한다.The present invention also provides dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, verdox, ethyl linalool , Beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis-3-hexenyl silicyl Rate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide, helional (helional), bacdanol, lemon oil, The effect of increasing concentration, characterized by mixing cedarwood oil, rosemary oil, bergamot oil, dipropylene glycol and black pepper oil It provides a method for producing a flavor mixture having a.
본 발명의 집중력 증가 효과를 지니는 향료 혼합물의 제조방법은, 보다 구체적으로는 향료 혼합물 총 중량 기준으로, 디하이드로 미르세놀(dihydro myrcenol) 2.2~2.8 중량%, 리나룰(linalool) 0.8~1.2 중량%, 리날릴 아세테이트(linalyl acetate) 0.8~1.2 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.3~2.7 중량%, 버독스(verdox) 2.8~3.2 중량%, 에틸 리나룰(ethyl linalool) 1.3~1.7 중량%, 베타 이오논(beta ionone) 2.8~3.2 중량%, 세드렘버(cedramber) 1.7~2.1 중량%, 릴리알(lilial) 7.7~8.3 중량%, 아이소 이 수퍼(iso e super) 9.2~9.8 중량%, 칼론(calone) 0.35~0.45 중량%, 암브로픽스(ambrofix) 1.8~2.2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.3~3.7 중량%, 헤디온(hedione) 10~11 중량%, 갈락솔라이드(galaxolide 50 ipm) 9.5~10.5 중량%, 토날라이드(tonalide) 3.5~4.5 중량%, 헬리오날(helional) 0.4~0.6 중량%, 박다놀(bacdanol) 0.8~1.2 중량%, 레몬 오일(lemon oil) 4.7~5.3 중량%, 시더우드 오일(cedarwood oil) 0.8~1.2 중량%, 로즈마리 오일(rosemary oil) 0.8~1.2 중량%, 버가못 오일(bergamot oil) 0.8~1.2 중량%, 디프로필렌 글리콜(dipropylene glycol) 25~26.5 중량% 및 블랙페퍼 오일(black pepper oil) 0.4~0.6 중량%를 혼합하여 제조할 수 있으며,The method for producing a perfume mixture having an effect of increasing concentration of the present invention is more specifically, based on the total weight of the perfume mixture, dihydro myrcenol 2.2 to 2.8 wt%, linalool 0.8 to 1.2 wt% , Linalyl acetate 0.8 to 1.2 wt%, methyl pamplemousse 2.3 to 2.7 wt%, verdox 2.8 to 3.2 wt%, ethyl linalool 1.3 to 1.7 wt %, beta ionone 2.8-3.2 wt%, cedramber 1.7-2.1 wt%, lilial 7.7-8.3 wt%, isoe super 9.2-9.8 wt% , Calone 0.35 to 0.45 wt%, ambrofix 1.8 to 2.2 wt%, cis-3-hexenyl salicylate 3.3 to 3.7 wt%, hedione ) 10-11 wt%, galaxolide 50 ipm 9.5-10.5 wt%, tonalide 3.5-4.5 wt%, helial 0.4-0.6 wt%, bacdanol 0.8- 1.2 wt%, lemon oil 4.7~5.3 wt%, cedarwood oil 0.8~1.2 wt%, rosemary oil 0.8~1.2 wt%, bergamot oil 0.8~1.2 It can be prepared by mixing wt%, dipropylene glycol 25~26.5 wt% and black pepper oil 0.4~0.6 wt%,
더욱 구체적으로는 향료 혼합물 총 중량 기준으로, 디하이드로 미르세놀(dihydro myrcenol) 2.5 중량%, 리나룰(linalool) 1 중량%, 리날릴 아세테이트(linalyl acetate) 1 중량%, 메틸 팜플레모스(methyl pamplemousse) 2.5 중량%, 버독스(verdox) 3 중량%, 에틸 리나룰(ethyl linalool) 1.5 중량%, 베타 이오논(beta ionone) 3 중량%, 세드렘버(cedramber) 1.9 중량%, 릴리알(lilial) 8 중량%, 아이소 이 수퍼(iso e super) 9.5 중량%, 칼론(calone) 0.4 중량%, 암브로픽스(ambrofix) 2 중량%, 시스-3-헥세닐 실리실레이트(cis-3-hexenyl salicylate) 3.5 중량%, 헤디온(hedione) 10.5 중량%, 갈락솔라이드(galaxolide 50 ipm) 10 중량%, 토날라이드(tonalide) 4 중량%, 헬리오날(helional) 0.5 중량%, 박다놀(bacdanol) 1 중량%, 레몬 오일(lemon oil) 5 중량%, 시더우드 오일(cedarwood oil) 1 중량%, 로즈마리 오일(rosemary oil) 1 중량%, 버가못 오일(bergamot oil) 1 중량%, 디프로필렌 글리콜(dipropylene glycol) 25.7 중량% 및 블랙페퍼 오일(black pepper oil) 0.5 중량%를 혼합하여 제조할 수 있다.More specifically, based on the total weight of the fragrance mixture, dihydro myrcenol 2.5% by weight,
본 발명은 또한, 상기 방법으로 제조된 집중력 증가 효과를 지니는 향료 혼합물을 제공한다.The present invention also provides a fragrance mixture having an effect of increasing concentration prepared by the above method.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only illustrative of the present invention, and the contents of the present invention are not limited to the following examples.
향료 시료의 준비Preparation of fragrance samples
본 발명의 아로마틱 마린 토닉 향료를 개발하는데 사용된 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리나릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스 쓰리 헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol)은 카스넘버(CAS Number)가 명확하게 명기된 시료를 국내의 원료공급업체로부터 구입하였다.Dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, verdox, used to develop the aromatic marine tonic fragrance of the present invention Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, cis Three hexenyl silicylate (cis-3-hexenyl salicylate), hedione, galaxolide (50 ipm), tonalide (helional), bacdanol (bacdanol), lemon oil (lemon oil), cedarwood oil, rosemary oil, bergamot oil, and dipropylene glycol are samples whose CAS Number is clearly specified. Purchased from a raw material supplier.
그리고 블랙페퍼 오일(blackpepper oil)은 수증기증류장치(EssenLab-Plus, HANIL LABTECH, Korea)를 사용하여 수행하였다. 수증기 증류장치의 수증기 발생부위에 2 L의 증류수를 넣고, 정유 발생부위에 블랙페퍼 시료 1 kg를 넣은 다음, 냉각관에는 4℃의 냉각수가 지속적으로 흐르도록 하였다. 수증기 발생부위의 온도를 100℃로 90분간 유지시키면서 수증기를 발생시켰고, 블랙페퍼에 함유된 정유는 냉각관에서 응축된 후 수용기에서 증류수층과 정유층으로 모였다. 순수한 정유만을 모으기 위하여 정유층을 무수황산나트륨이 담겨있는 삼각깔대기에 통과시켜 수분과 불순물을 제거시켰으며, 수집된 정유는 4℃의 냉장고에서 보관하였다.And black pepper oil (blackpepper oil) was carried out using a steam distillation apparatus (EssenLab-Plus, HANIL LABTECH, Korea). 2 L of distilled water was put in the steam generating part of the steam distillation apparatus, 1 kg of black pepper sample was put in the generating part of the refinery, and then the cooling water of 4℃ was continuously flowed through the cooling pipe. Water vapor was generated while maintaining the temperature of the steam generating part at 100°C for 90 minutes, and the essential oil contained in the black pepper was condensed in a cooling tube and then collected in a distilled water layer and a refined oil layer in the receiver. In order to collect only pure essential oil, the essential oil layer was passed through a triangular funnel containing anhydrous sodium sulfate to remove moisture and impurities, and the collected essential oil was stored in a refrigerator at 4℃.
제조예Manufacturing example 1. One. 아로마틱Aromatic 마린Marine 토닉tonic 향취의 향료 조성물 개발 Development of fragrance composition of fragrance
본 발명의 아로마틱 마린 토닉 향취는 시원한 바다의 향취와 풍부한 아로마의 향기가 주는 느낌이 복합적으로 표현된 것이다. 신규의 아로마틱 마린 토닉 향취를 갖는 조성물을 개발하기 위하여 디하이드로 미르세놀(dihydro myrcenol), 리나룰(linalool), 리나릴 아세테이트(linalyl acetate), 메틸 팜플레모스(methyl pamplemousse), 버독스(verdox), 에틸 리나룰(ethyl linalool), 베타 이오논(beta ionone), 세드렘버(cedramber), 릴리알(lilial), 아이소 이 수퍼(iso e super), 칼론(calone), 암브로픽스(ambrofix), 시스 쓰리 헥세닐 실리실레이트(cis-3-hexenyl salicylate), 헤디온(hedione), 갈락솔라이드(galaxolide 50 ipm), 토날라이드(tonalide), 헬리오날(helional), 박다놀(bacdanol), 레몬 오일(lemon oil), 시더우드 오일(cedarwood oil), 로즈마리 오일(rosemary oil), 버가못 오일(bergamot oil), 디프로필렌 글리콜(dipropylene glycol), 블랙페퍼 오일(black pepper oil)을 하기 표 1과 같이 혼합하여 7종을 개발하였다.The aromatic marine tonic scent of the present invention is a complex expression of the scent of the cool sea and the scent of rich aroma. To develop a composition having a novel aromatic marine tonic scent, dihydro myrcenol, linalool, linalyl acetate, methyl pamplemousse, and verdox , Ethyl linalool, beta ionone, cedramber, lilial, iso e super, calone, ambrofix, Cis-3-hexenyl salicylate, hedione, galaxolide 50 ipm, tonalide, helional, bacdanol, lemon Oil (lemon oil), cedarwood oil (cedarwood oil), rosemary oil (rosemary oil), bergamot oil (bergamot oil), dipropylene glycol (dipropylene glycol), black pepper oil (black pepper oil) as shown in Table 1 below. Seven kinds were developed by mixing.
향료
1Combination
Spices
One
향료
2Combination
Spices
2
향료
3Combination
Spices
3
향료
4Combination
Spices
4
향료
5Combination
Spices
5
향료
6Combination
Spices
6
향료
7Combination
Spices
7
실시예Example 1. One. 아로마틱Aromatic 마린Marine 토닉tonic 향료 조성물에 대한 소비자 선호도 조사 Consumer preference survey for perfume composition
본 제조예 1에서 조향된 7개의 조합향료에 대한 선호도 조사를 10-30대의 일반 소비자 50명을 대상으로 시향지(0.5 cm × 13 cm)에 적신 다음, 코로부터 5 cm 되는 위치에서 향을 맡게 하고 가장 선호하는 향료에 10점, 가장 비선호하는 향료에 0점을 주도록 하였다. 선호도 결과를 바탕으로 평균값을 구하였고, 이를 표 2에 나타내었다. The preference survey for the 7 combination perfumes steered in Preparation Example 1 was conducted for 50 general consumers in their 10s and 30s, soaked in a vision paper (0.5 cm × 13 cm), and smelled at a
아로마틱 마린 토닉 향취 조성물 7종에 대한 선호도 조사 결과 조합향료 6의 조성물이 8.9점으로 가장 높은 점수를 나타내어 선호도가 가장 높게 나타났고, 선호도가 가장 낮았던 것은 조합향료 5로 선호도가 3.4점으로 나타났다.As a result of the preference survey for 7 kinds of aromatic marine tonic fragrance composition, the composition of the
실시예Example
2. 2.
아로마틱Aromatic
마린Marine
토닉tonic
향취의 조합향료 6이 인간의 뇌파에 미치는 영향 The Effect of
실시예 1을 통하여 소비자 선호도가 가장 높았던 조합향료 6을 흡입시에 인간의 뇌 활동에는 어떠한 영향을 미치는지를 알기 위하여 뇌파(Electroencephalogram, EEG)를 측정하였다. 뇌파측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4 m2 크기의 실험실에서 남녀 각각 10명씩 총 20명의 피험자를 대상으로 수행하였다.EEG (Electroencephalogram, EEG) was measured to find out what effect the
본 실시예에서 뇌파측정을 위해 사용한 뇌파측정기기는 QEEG-32 System (LAXTHA Inc. Korea)이었으며, 피험자의 뇌파신호 측정은 LAXTHA의 데이터 수집 장비 및 분석프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준 전극 부착법을 이용하여 32개의 접지전극을 뇌파전용 Electro-Gel(Electro-Cap Internationals, Inc. U.S.A.)을 사용하여 좌측과 우측 전전두엽(Fp1, Fp2, Fpz, Af3, Af4, Afz), 좌측과 우측 전두엽(F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), 좌측과 우측 측두엽(T3, T4, T7, T8, Cp5, Cp6), 좌측과 우측 두정엽(P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), 좌측과 우측 후두엽(O1, O2, Oz) 부분에 부착하고 왼쪽과 오른쪽 귓볼에도 각각 하나씩의 레퍼런스 전극을 부착하였다. 윗면 지름 5 cm, 높이 4.8 cm, 아랫면 지름 3.5 cm의 종이컵에 가로 3.5 cm, 세로 4 cm의 거즈를 넣고 피펫을 이용해 향료를 첨가하여 거즈에 고루 뭍인 후, 피험자의 코로부터 약 5 cm 거리를 유지하고 피험자가 눈을 감은 상태에서 아로마틱 마린 토닉 조합향료 6 흡입 전(무자극)과 흡입 상태(향자극)로 하여 각각 60초씩 측정하였다.In this example, the EEG measurement device used for EEG measurement was the QEEG-32 System (LAXTHA Inc. Korea), and the data collection equipment and analysis program (Telescan) of LAXTHA were used to measure the EEG signal of the subject. To the subjects, 32 grounding electrodes were attached to the left and right frontal lobes (Fp1, Fp2, Fpz, Af3, Af4) using Electro-Gel (Electro-Cap Internationals, Inc. USA) for EEG using 10-20 international standard electrode attachment method. , Afz), left and right frontal lobes (F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), left and right temporal lobes (T3, T4, T7, T8, Cp5, Cp6), left and right parietal lobes (P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), left and right occipital lobes (O1, O2, Oz) were attached, and one reference electrode was attached to the left and right earlobe, respectively. Put gauze 3.5 cm wide and 4 cm long into a paper cup with a top diameter of 5 cm, a height of 4.8 cm, and a bottom diameter of 3.5 cm, add flavoring using a pipette, and spread it evenly on the gauze, keeping a distance of about 5 cm from the subject's nose. The subjects were measured for 60 seconds each before inhalation (no stimulation) and inhalation condition (scent stimulation) with the subject's eyes closed.
본 실시예에서 아로마틱 마린 토닉 조합향료 6에 대한 뇌파측정을 통해 얻어진 데이터 처리는 피험자의 뇌파신호 중 대표적인 50초간의 뇌파신호만을 추출하여 뇌파일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(SPSS 18.0 version)를 이용하여 대응표본 T 검정을 수행하였다. 본 실시예에서 아로마틱 마린 토닉 향료 흡입 전(무자극)과 흡입 중(향자극)에 얻는 데이터 분석을 위한 뇌파지표의 종류는 표 3에, 그리고 각각의 뇌파 지표의 의미는 표 4에 나타내었다.In the present embodiment, the data processing obtained through the EEG measurement for the aromatic marine
본 발명의 실시예 1에서 가장 선호도가 높았던 조합향료 6이 인간의 뇌파에 미치는 영향을 분석한 결과, 25개의 지표 중 RG 파워 스펙트럼, RLB 파워 스펙트럼, SEF50 파워 스펙트럼만 통계학적으로 유의성이 있는 것으로 나타났고(p<0.05), 나머지 22개의 파워스펙트럼은 향자극 전후에 큰 차이가 없었기 때문에 본 명세서에는 기술하지 않았다.As a result of analyzing the effect of the
1. RG(Relative gamma power spectrum)1.RG (Relative gamma power spectrum)
조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과, 전극 부착부위인 전전두엽 Afz과 전두엽 Fc6 부위에서 RG 지표가 통계학적으로 유의미(p<0.05)하게 증가하였다(표 5). RG 지표는 뇌파 스펙트럼에서 전체 주파수 영역의 절대파워에 대한 gamma 대역의 절대파워 비로서, gamma파 영역(30~50 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어 준 스펙트럼 값을 의미한다. Gamma파는 두뇌 활동 파장 중 가장 속파에 속하며, 정서적으로 초조한 상태이거나 추리, 판단 등의 고도의 인지작용 시 활성화된다고 알려져 있다. 조합향료 6의 흡입으로 RG가 증가하였다는 것은 뇌의 인지작용이 증가하였다는 것을 알 수 있다.As a result of measuring the EEG before and during the inhalation of the
2. RLB(Relative low beta power spectrum)2. Relative low beta power spectrum (RLB)
조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과 전극 부탁부위인 전두엽 Fc2, 두정엽 Cz 부위에서 RLB 지표가 증가하였다(표 6). RLB 지표는 뇌파 스펙트럼에서 전체 주파수영역의 절대파워에 대한 low beta 대역의 절대파워 비로서 low beta파 영역(12~15 Hz)을 전체 주파수 영역(4~50 Hz)으로 나누어 준 스펙트럼 값을 의미한다. 조합향료 6의 흡입으로 RLB가 증가하였다는 것은 뇌의 집중도가 증가하였다는 것을 알 수 있다.As a result of measuring EEG before and during inhalation of the
3. SEF50(Spectral edge frequency 50%)3. SEF50(Spectral edge frequency 50%)
조합향료 6을 흡입 전과 흡입 중에 뇌파를 측정한 결과 전극 부착부위인 전두엽 Fc6 부위에서 SEF50 지표가 증가하였다(표 7). SEF50은 인지활동에 대한 대뇌피질의 활성을 알아보기 위한 기준척도로 작업부하도나 각성상태를 알아볼 수 있다. 뇌파 파워 스펙트럼 분포가 저주파에 비해서 고주파 쪽으로 얼마나 편향되었는지를 주파수로 정량화하는 방법으로 전체 주파수 영역에 대한 면적비로 표시되는데, SEF 값이 높을수록 파워 스펙트럼 분포에서 상대적으로 높은 주파수 성분이 많이 나왔음을 의미한다. SEF50 지표는 뇌의 각성을 나타내며, 영역구분에 의한 기존의 분석법보다 예리하고 심도 있는 지표로서 파워 스펙트럼에서 낮은 주파수 축에서부터 면적을 계산하고 그 면적이 전체 주파수 면적의 반이 되는 지점의 주파수 값을 의미한다. 조합향료 6의 흡입으로 SEF50이 증가하였다는 것은 뇌의 각성상태가 증진되었다는 것을 알 수 있다.As a result of measuring EEG before and during inhalation of the
본 발명의 실시예에서 명확하게 나타난 바와 같이 조합향료 6은 흡입하였을 때 중앙 전전두엽(Afz) 및 우측 전두엽(Fc6) 부위에서 RG 지표, 중앙 두정엽(Cz) 및 우측 전두엽(Fc2) 부위에서 RLB 지표, 우측 전두엽(Fc6) 부위에서 SEF50 지표를 증가시켜 뇌의 인지능력 및 각성도를 증가시켜 집중력을 증진시켰다는 것을 나타낸다. 본 발명의 실시예의 모든 결과들은 조합향료 6의 흡입시 뇌의 집중력이 고도로 증가한다는 것을 나타낸다.As clearly shown in the examples of the present invention, when inhaled, the
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190019916A KR102151758B1 (en) | 2019-02-20 | 2019-02-20 | Aromatic aroma composition for enhancing concentration of human brain and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190019916A KR102151758B1 (en) | 2019-02-20 | 2019-02-20 | Aromatic aroma composition for enhancing concentration of human brain and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200102037A KR20200102037A (en) | 2020-08-31 |
KR102151758B1 true KR102151758B1 (en) | 2020-09-03 |
Family
ID=72234424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190019916A KR102151758B1 (en) | 2019-02-20 | 2019-02-20 | Aromatic aroma composition for enhancing concentration of human brain and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102151758B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230128842A (en) | 2022-02-28 | 2023-09-05 | (주) 레비레스코 | Natural aroma composition with anti-aging effect through activating stem cells and protecting from UV |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000355696A (en) | 1999-04-12 | 2000-12-26 | Kao Corp | Perfume composition |
JP2002154951A (en) | 2000-09-08 | 2002-05-28 | Hayashibara Bijutsu Minto:Kk | Brain wave inhibitor |
JP2005290379A (en) | 2004-04-02 | 2005-10-20 | Amorepacific Corp | Perfume composition having physiological or psychological therapeutic effect |
KR101349592B1 (en) | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09302377A (en) * | 1996-05-08 | 1997-11-25 | Pola Chem Ind Inc | Stress-relaxing perfume and composition containing the same |
-
2019
- 2019-02-20 KR KR1020190019916A patent/KR102151758B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000355696A (en) | 1999-04-12 | 2000-12-26 | Kao Corp | Perfume composition |
JP2002154951A (en) | 2000-09-08 | 2002-05-28 | Hayashibara Bijutsu Minto:Kk | Brain wave inhibitor |
JP2005290379A (en) | 2004-04-02 | 2005-10-20 | Amorepacific Corp | Perfume composition having physiological or psychological therapeutic effect |
KR101349592B1 (en) | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230128842A (en) | 2022-02-28 | 2023-09-05 | (주) 레비레스코 | Natural aroma composition with anti-aging effect through activating stem cells and protecting from UV |
Also Published As
Publication number | Publication date |
---|---|
KR20200102037A (en) | 2020-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102151761B1 (en) | Aquatic aroma composition for relaxation and enhancing concentration of human brain and uses thereof | |
KR101855737B1 (en) | Aroma composition with buleberry flavor for relaxation and uses thereof | |
KR101077018B1 (en) | Cosmetic Composition with Anti-stress and Relaxing Effect | |
KR20120131970A (en) | Perfume composition with antistress and relexing effect, and cosmetic composition comprising the same | |
KR101714543B1 (en) | Aroma composition for psycholigical stability and reducing stress comprising Schisandra chinensis essential oil and Angelica gigas essential oil as effective component | |
KR101843977B1 (en) | Essential Oil Compound from Chamaecyparis obtusa and Cupressaceae and Abies koreana WILS to increase RSMT (ratio of (SMR~Mid beta) to theta), RB (relative beta power spectrum), RMT (ratio of mid beta to theta), AFA(absolute fast alpha power spectrum) | |
KR102151758B1 (en) | Aromatic aroma composition for enhancing concentration of human brain and uses thereof | |
KR102060958B1 (en) | Tropical passion flower aroma composition for enhancing concentration of human brain and uses thereof | |
KR102060960B1 (en) | Aroma composition having fragrance of sensual luminous flower for brain pleasant and comfort | |
KR102060957B1 (en) | Deep forest mix aroma composition for enhancing concentration of human brain and uses thereof | |
KR20190119824A (en) | Perfume composition for decreasing relative theta wave and relative alpha wave of brainwave containing essential oil of Chrysanthemum indicum L and use thereof | |
KR101533673B1 (en) | Perfume composition for expressing the fragrance of gardenia jasminoides Ellis for. Grandiflora Makino | |
KR102506628B1 (en) | Aqua green Abies koreana aroma composition for enhancing comfort and concentration of human brain | |
KR102506624B1 (en) | Fruity floral Abies koreana aroma composition for enhancing concentration of human brain | |
KR102570019B1 (en) | A foot massage composition for aromatherapy | |
KR102340205B1 (en) | Aroma composition with woody fragrance increasing brain concentration and awakening | |
KR102369379B1 (en) | Aroma composition with gourmand floral fragrance for relieving stress | |
KR102363321B1 (en) | Aroma composition with green citrus fragrance increasing brain refreshment and awakening | |
KR102001127B1 (en) | Aroma composition for enhancing concentration by decreasing RSA power spectrum in the prefrontal lobe Fc5 site and increasing RHB power spectrum in the prefrontal lobe Af3 site and parietal lobe Af3 site and uses thereof | |
KR101877290B1 (en) | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof | |
KR101355307B1 (en) | Perfume composition for expressing the fragrance of aconitum pseudolaeve nakai | |
KR101313255B1 (en) | Fragrance compound containing the essential oil from Heracleum moellendorffii | |
KR101538417B1 (en) | Composition of Cnidium officinale Makino essential oil and cosmetic having there | |
KR20210135741A (en) | Aroma composition with gourmand floral fragrance releasing brain stress | |
KR20190061234A (en) | Aroma composition enhances psychological stability of human by increasing the relative fast alpha activity at T8 region and decreasing the relative gamma activity at Cp6 region and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |